In the context of lung cancer, levels of TF have been found to be upregulated in the lung tissue and plasma of NSCLC patients [123], with an up to 41-fold increase in levels reported in the case of a giant-cell lung carcinoma patient with Trousseau’s syndrome [124]. Here, TF is linked to lung carcinoma.